Know why women around 30 to 35 should do timely examinations to avoid cervical cancer
Cervical cancer remains a silent threat, especially for women aged 30-35. Timely screenings can detect early warning signs, ...
Pharmabiz17h
China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab
China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab: Hong Kong Friday, November 29, 2024, 10:00 Hrs [IST] Akeso, Inc., a leading biopharmace ...
Knowridge21h
Gold beats platinum in fighting cancer, study finds
Gold is shining in a surprising new way—not as jewelry, but as a potential cancer treatment. Researchers from RMIT University ...
pharmaphorum22h
Kelun's MSD-partnered TROP2 drug gets first okay in China
The approval means Kelun has brought its TROP2 ADC to market ahead of AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan ...
Frontiers15h
Mechanisms and Complexities Underlying the Cancer Cell Immune Evasion and its Therapeutic Implications
The three main methods used to treat cancer are surgical excision, chemotherapy, and radiation therapy. Immunotherapy has had a major impact on the prognosis for treating cancers like renal cell ...